Christopher R. Loose, Chief Scientific Officer at Frequency Therapeutics, Inc. (FREQ), sold 7,106 shares at $21.57 ($151K) on 2020-09-23, disclosed to the SEC on 2020-09-25.
Open-market sale of $151k FREQ by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.51 | 1,870 | $38K | 25.3% |
| 2 | $21.57 | 2,606 | $56K | 37.1% |
| 3 | $21.57 | 2,606 | $56K | 37.1% |
| 4 | $22.43 | 24 | $538 | 0.4% |
| Total | $21.29 avg | 7,106 | $151K | 100% |
| Filing → |
| FREQ | SELL | 2023-07-25 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-21 | $2K | — | Filing → |
| FREQ | SELL | 2023-07-19 | $2K | — | Filing → |